Half of Patients With Post-BCG Bladder Cancer Achieve CR With Nonviral Gene Therapy

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — WASHINGTON — More than half of previously treated non-muscle-invasive bladder cancer (NMIBC) patients had complete responses (CR) with intravesical gene therapy, according to preliminary results from an ongoing study…




